Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Genomic Screening of Wistar and Wistar-Kyoto Rats Exposed to Chronic Mild Stress and Deep Brain Stimulation of Prefrontal Cortex.

Papp M, Gruca P, Faron-Górecka A, Kusmider M, Willner P.

Neuroscience. 2019 Nov 6;423:66-75. doi: 10.1016/j.neuroscience.2019.10.015. [Epub ahead of print]

PMID:
31705885
2.

Behavioural aspects of neuroinflammation.

Willner P, Vanderschuren L, Bergman J.

Behav Pharmacol. 2019 Dec;30(8):624-625. doi: 10.1097/FBP.0000000000000518. No abstract available.

PMID:
31703027
3.

Functional lateralization in the prefrontal cortex of dopaminergic modulation of memory consolidation.

Papp M, Gruca P, Lason M, Niemczyk M, Willner P.

Behav Pharmacol. 2019 Sep;30(6):514-520. doi: 10.1097/FBP.0000000000000483.

PMID:
31033526
4.

The behavioural pharmacology of stress-related disorders.

Willner P, Bergman J, Vanderschuren L.

Behav Pharmacol. 2019 Apr;30(2 and 3-Spec Issue):101-103. doi: 10.1097/FBP.0000000000000481. No abstract available.

PMID:
30882423
5.

The role of prefrontal cortex dopamine D2 and D3 receptors in the mechanism of action of venlafaxine and deep brain stimulation in animal models of treatment-responsive and treatment-resistant depression.

Papp M, Gruca P, Lason M, Niemczyk M, Willner P.

J Psychopharmacol. 2019 Jun;33(6):748-756. doi: 10.1177/0269881119827889. Epub 2019 Feb 21.

PMID:
30789286
6.

Announcement of Special Issues for 2019: Stress and Neuroinflammation.

Willner P, Bergman J, Vanderschuren L, Ellenbroek B.

Behav Pharmacol. 2018 Dec;29(8):667. doi: 10.1097/FBP.0000000000000458. No abstract available.

PMID:
30418201
7.

The pharmacology of executive functioning: part 2: research reports.

Jack B, Louk V, Ellenbroek B, Paul W.

Behav Pharmacol. 2018 Dec;29(8):665-666. doi: 10.1097/FBP.0000000000000457. No abstract available.

PMID:
30418200
8.

The pharmacology of executive functioning.

Jack B, Louk V, Bart E, Paul W.

Behav Pharmacol. 2018 Oct;29(7):557-558. doi: 10.1097/FBP.0000000000000444. No abstract available.

PMID:
30212409
9.

Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.

Willner P, Gruca P, Lason M, Tota-Glowczyk K, Litwa E, Niemczyk M, Papp M.

Behav Pharmacol. 2019 Apr;30(2 and 3-Spec Issue):239-250. doi: 10.1097/FBP.0000000000000431.

PMID:
30204592
10.

Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression.

Papp M, Gruca P, Lason M, Tota-Glowczyk K, Niemczyk M, Litwa E, Willner P.

J Psychopharmacol. 2018 Oct;32(10):1133-1140. doi: 10.1177/0269881118791737. Epub 2018 Sep 5.

PMID:
30182787
11.

Effects on brain-derived neurotrophic factor signalling of chronic mild stress, chronic risperidone and acute intracranial dopamine receptor challenges.

Papp M, Gruca P, Lason-Tyburkiewicz M, Litwa E, Niemczyk M, Tota-Glowczyk K, Faron-Gorecka A, Kusmider M, Solich J, Szlachta M, Willner P.

Behav Pharmacol. 2018 Sep;29(6):537-542. doi: 10.1097/FBP.0000000000000392.

PMID:
29537988
12.

The UK Mental Capacity Act and consent to research participation: asking the right question.

Willner P.

J Med Ethics. 2018 Jan;44(1):44-46. doi: 10.1136/medethics-2016-103996. Epub 2017 Aug 5.

PMID:
28780523
13.

Dopaminergic mechanisms in memory consolidation and antidepressant reversal of a chronic mild stress-induced cognitive impairment`.

Papp M, Gruca P, Lason-Tyburkiewicz M, Litwa E, Niemczyk M, Tota-Glowczyk K, Willner P.

Psychopharmacology (Berl). 2017 Sep;234(17):2571-2585. doi: 10.1007/s00213-017-4651-4. Epub 2017 May 31.

14.

Sleep does not cause false memories on a story-based test of suggestibility.

van Rijn E, Carter N, McMurtrie H, Willner P, Blagrove MT.

Conscious Cogn. 2017 Jul;52:39-46. doi: 10.1016/j.concog.2017.04.010. Epub 2017 Apr 27.

PMID:
28458092
15.

The chronic mild stress (CMS) model of depression: History, evaluation and usage.

Willner P.

Neurobiol Stress. 2016 Aug 24;6:78-93. doi: 10.1016/j.ynstr.2016.08.002. eCollection 2017 Feb. Review.

16.

Reliability of the chronic mild stress model of depression: A user survey.

Willner P.

Neurobiol Stress. 2016 Aug 22;6:68-77. doi: 10.1016/j.ynstr.2016.08.001. eCollection 2017 Feb.

17.

Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression.

Papp M, Gruca P, Lason-Tyburkiewicz M, Willner P.

Behav Pharmacol. 2017 Feb;28(1):1-8. doi: 10.1097/FBP.0000000000000259.

PMID:
27759570
18.

CBT in a Caribbean Context: A Controlled Trial of Anger Management in Trinidadian Prisons.

Hutchinson G, Willner P, Rose J, Burke I, Bastick T.

Behav Cogn Psychother. 2017 Jan;45(1):1-15. Epub 2016 Sep 15.

PMID:
27629438
19.

Assessment of Anger-Related Cognitions of People with Intellectual Disabilities.

Richardson C, Killeen S, Jahoda A, Christopher R, Rose J, Willner P.

Behav Cogn Psychother. 2016 Sep;44(5):580-600. doi: 10.1017/S1352465816000059. Epub 2016 Mar 28.

PMID:
27019114
20.

Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats.

Papp M, Gruca P, Lason-Tyburkiewicz M, Willner P.

Psychopharmacology (Berl). 2016 Apr;233(7):1235-43. doi: 10.1007/s00213-016-4206-0. Epub 2016 Jan 15.

Supplemental Content

Loading ...
Support Center